Finch Therapeutics Group, Inc., (FNCH) Social Stream
FINCH THERAPEUTICS GROUP INC (FNCH) Price Targets From Analysts
Use the tables below to see what analysts covering FINCH THERAPEUTICS GROUP INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-10 | 3 | $34 | $26 | $29.666 | $0.4 | 7316.5% |
| 2022-03-18 | 3 | $34 | $27 | $30 | $0.4 | 7400% |
| 2022-04-01 | 3 | $34 | $20 | $27.666 | $0.4 | 6816.5% |
| 2022-04-04 | 3 | $34 | $17 | $23.666 | $0.4 | 5816.5% |
| 2022-04-29 | 2 | $20 | $17 | $18.5 | $0.4 | 4525% |
| 2022-05-16 | 2 | $17 | $11 | $14 | $0.4 | 3400% |
| 2022-08-09 | 3 | $17 | $11 | $15 | $0.4 | 3650% |
| 2022-08-13 | 3 | $17 | $10 | $14.666 | $0.4 | 3566.5% |
| 2022-11-11 | 3 | $17 | $6 | $13.333 | $0.4 | 3233.25% |
| 2023-01-24 | 3 | $17 | $3 | $12.333 | $0.4 | 2983.25% |
The Trend in the Analyst Price Target
FNCH's average price target has moved down $17.34 over the prior 16 months.
FNCH reports an average of 722.01% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-04 | 2 | 20 | 17 | 18.500 | 5.110 | 262.04% |
| 2022-09-01 | 3 | 17 | 6 | 13.333 | 2.100 | 534.9% |
| 2022-11-11 | 3 | 17 | 6 | 13.333 | 1.070 | 1146.07% |
| 2023-01-05 | 3 | 17 | 3 | 12.333 | 0.510 | 2318.24% |
| 2023-01-24 | 3 | 17 | 3 | 12.333 | 0.495 | 2391.52% |
FNCH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
Over the past 39 weeks, FNCH's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FNCH as an investment opportunity.
- In the context of all US stocks, FINCH THERAPEUTICS GROUP INC's upside potential (average analyst target price relative to current price) is higher than 1292.94% of them.
- In the context of all US stocks, FINCH THERAPEUTICS GROUP INC's number of analysts covering the stock is greater than 100.87% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, FINCH THERAPEUTICS GROUP INC's variance in analysts' estimates is lower than -291.28% of them.
- In the context of Healthcare stocks, FINCH THERAPEUTICS GROUP INC's average analyst price target is greater than 435.66% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FINCH THERAPEUTICS GROUP INC are IKNA, ACHL, and VECT.
View All Top Stocks by Price Target
What is the outlook for FNCH? Use POWR Ratings for clearer insight into price direction.